Todos Med Ltd (TOMDF)

[Sloan89RH]

I appreciate your perspective regarding the Todos approach to using influencers. And, their approach may have merit. But, if we step back and ask ourselves the following: what are the demographic groups that stand to gain the most from Tollovid/Tollovir, I think we'd have to primarily focus on the elderly, those who are immune compromised, and those in nursing homes. Many elderly have a poor immune response to vaccines and remain very vulnerable even though fully vaccinated and boosted. Targeting Tollovid to this group needs to be a high priority. This demographic group gets first priority to vaccines. It seems to make sense that this group would also be the main focus of any marketing campaign for Tollovid.